The model drug selected was amlodipine besylate. Amlodipine besylate is chemically described as 3-Ethyl-5-methyl (±)-2-[(2-aminoethoxy) methyl] -4-(2-chlorophenyl)-1, 4-d ihydro -6-methyl-3, 5-pyridinedicarbo xy late, mono benzenesulphonate monohydrate.
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Amlodipine is a dihydropyridine calciu m antagonist (calciu m ion antagonist or slow-channel blocker) that inhibits the transmembrane influ x of calciu m ions into vascular smooth muscle and cardiac muscle. Experimental data suggest that amlodip ine binds to both dihydropyridine and non dihydropyridine binding sites. The contractile processes of cardiac muscle and vascular smooth muscle are dependent upon the movement of extra cellu lar calciu m ions into these cells through specific ion channels. Amlodipine inhibits calciu m ion influ x across cell memb ranes selectively, with a greater effect on vascular smooth muscle cells than on cardiac muscle cells.
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Generally, the following points are considered for patient compliance in case of anti-angina patients, a rapid onset of action is necessary for immediate pain relief, patient has difficulty to swallow tablet or any another dosage form during pain, geriatrics has difficulty to swallow the dosage form. By considering the above points, patient convenience and compliance oriented research has resulted in bringing out safer and newer drug delivery systems one of such approach is fast dissolving drug delivery system.
ABS TRACT:
Fast-dissolving drug-delivery systems were first developed in the late 1970s as an alternative to tablets, capsules, and syrups. Fast dissolving oral films (FDOFs) are the most advanced form of oral solid dosage form due to more flexibility and comfort. It improve the efficacy of APIs by dissolving within minute in oral cavity after the contact with less saliva as compared to fast dissolving tablets, without chewing and no need of w ater for administration. The FDOFs place as an alternative in the market due to the consumer's preference for a fast dissolving product over conventional tablets / capsules. The oral thin-film technology is still in the beginning stages and has bright future ahead because it fulfils all the need of patients. Eventually, film formulations having drug/s will be commercially launched using the oral film technology. In the present study fast dissolving film of Amlodipine Besylate was prepared using sodium alginate as film forming polymer. To decrease the disintegration time of formulations sodium starch glycolate was used as disintegrating agent. A full 3 2 factorial design was applied using concentration of polymer and disintegrant as independent variable and disintegration time and % cumulative drug release as dependent variable. Response surface curves were plotted. Batch F6 was found to be the optimized batch as its disintegration was completed within the minimum time as compared to all other batches. The formulation (F6) was also showing sufficient drug release after 6 min. All the nine formulation was showing approximately 70-85% drug release after 6 min. Keywords: Amlodipine Besylate, fast dissolving film, solvent casting, response surface plot, sodium algin ate.
Conventional dosage forms for the anti-angina therapy includes tablets and injections. Injections provide effective rapid relief but, they are very painfu l and very expensive.
Sodiu m starch glycolate is widely used in oral pharmaceuticals as a disintegrant in capsule and tablet formulat ions. It is common ly used in tablets prepared by either direct-co mpression or wet granulation processes. The usual concentration employed in a formu lation is between 2% and 8%, with the optimu m concentration about 4%, although in many cases 2% is sufficient. Disintegration occurs by rapid uptake of water followed by rapid and enormous swelling. 5 Glycerin is used in a wide variety of pharmaceutical formu lations including oral, ophthalmic, topical, and parenteral preparations. It is also frequently used as a plasticizer in film coatings and preparation of soft gelatin capsules.
MATERIALS AND METHODS:-
Amlodipine Besylate hydrochloride was obtained as a gift sample fro m Hilab Chemicals ltd., Go regaon, Mumbai(India). Sodiu m alginate, Sodiu m Starch Glycolate and glycerine were purchased from Hilab Chemicals ltd., Go regaon, Mumbai (India). A ll other chemicals and reagent were of analytical g rade.
COMPATIB ILITY S TUDIES:-Fourier Transform Infrared S pectr oscopy (FT-IR):
FT-IR spectroscopy was carried out for the following : (a) pure drug amlodip ine besylate (b) amlodipine besylate with Sodiu m alginate (c) amlodipine besylate with SSG using Perkin Elmer FTIR model 163 by taking KBr d isc.
Formul ation of fil ms :-
For formu lating the film sodium alg inate was dissolved in distilled water. A mlodip ine Besylate and sodium starch glycolate was added to the polymer solution. When the entire solid material was dissolved in the water, required amount of plasticizer (glycerol) was added to the solution. The solution was then casted on the plastic films and dried in oven at 60 0C. Dried films were removed and stored in desiccator till further use. 
EVALUATION OF FILMS:
Thickness:
All the batches were evaluated for thickness by using calibrated Vernier caliper. Th ree read ings from all the batches were taken and mean thickness was evaluated.
Fol ding endurance:
The folding endurance was measured manually fo r the prepared films. A strip of film was cut and repeatedly folded at the same place till it broke. The number of times the film could be folded at the same place without breaking gave the value of fo lding endurance.
Drug content:
Drug content of all n ine batches was determined by UVSpectrophotometric method. For this 1x1 cm2 strip fro m the each film was cut and dissolved in 10ml of simu lated salivary flu id (pH 6.2). The solution was filtered and absorbance was recorded at 239 n m. Drug content was calculated by using standard curve of drug.
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Uniformity of drug content:
For determin ing the uniformity of drug content in the film at least three strips (1x1 cm2) were cut fro m different section of the film and drug content was calculated for all three strips using the same procedure as above. The drug content of all three strips was compared. Same procedure was repeated for all the nine batches .
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In vi tro disintegrati on ti me:
In vitro disintegration time is determined visually in a glass dish of 25ml distilled water with swirling every 10 sec. The disintegration time is the time when the film starts to break or disintegrates. 
In-vi tro dissolution studies:
Dissolution study was carried out in USP basket type apparatus using the stimu lated salivary fluid (pH 6.2) as a dissolution mediu m at 50 rotations per minute. 5ml aliquots were withdrawn at different time intervals and same amount of fresh dissolution mediu m was added. The aliquots were assayed for drug content at 230.5n m wavelength using UV-spectrophotometer. The cu mulative percentage drug release was calculated.
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RES ULT AND DISCUSSION:-Fast dissolving films were prepared using sodium alg inate as film forming poly mer and sodium starch glycolate as disintegrating agent. The films were evaluated for various properties such as thickness, drug content etc. The result showed that all the films have a smooth surface and good folding endurance. Drug content of all the films was between 4.6 to 5.01mg. The results are shown in table 2.
The results of weight and drug content uniformity test showed that the film was uniform and drug was also uniformly distributed in the films. Films were having thickness adequate for handling and use. The disintegration time o f the films was evaluated using simu lated salivary fluid (pH 6.2). Two times readings for each batch were recorded i.e. t ime at wh ich disintegration started and time when the film co mpletely disintegrates.
The result indicates that disintegration of films in itialized in about 30 sec and completes in 142-197 sec. Batch F3 and F6 disintegrates most rapidly. The results of in-vitro dissolution of all batches are shown in figure.1 A full 3 2 factorial design was applied to study the effect of independent variables (conc. of sodium alginate and conc. of sodium starch glycolate) on the dependent variable (disintegration time and % cumu lative drug release after 6 min). Various coefficients have been shown in table3.
Response surface plots were plotted which are shown in figure 2 & figure 3 . Response surface plots showed that the % cumulat ive drug release after 6 minutes inversely proportional to the concentration of sodium alg inate and directly proportional to concentration of sodium starch glycolate. The disintegration time is inversely proportional to concentration of SSG and directly proportional to concentration of sodium alginate. 
CONCLUS ION:
It was concluded that the fast dissolving strips of amlodipine besylate can be made by solvent casting technique with enhanced dissolution rate, taste masking, and hence better patient compliance and effect ive therapy.
